Journal of Interventional Cardiology / 2020 / Article / Tab 3

Research Article

Analysis of Atrial Fibrillation Treatment Regimes in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients

Table 3

Anticoagulation, CHA2DS2-VASc score, and AF treatment regimens with corresponding medication and interventions.

Paroxysmal AF, n = 119Persistent AF, n = 102Permanent AF, n = 152 value

Vitamin K antagonist42.9%49.0%61.8%0.01
Direct oral anticoagulants47.9%44.2%28.3%0.01
CHA2DS2-VASc score5.1 ± 1.44.9 ± 1.35.1 ± 1.30.5

Rate controln = 60
Class II AAD90.0%80.9%0.25
Class II AAD + digitalis3.3%11.8%<0.001
Pacemaker ± AVN ablation10.0%21.7%<0.0001

Rhythm controln = 42
Class I AAD0.8%0.0%1
Class II AAD58.0%
Class III AAD2.5%16.7%0.0034
Class IV AAD0.0%0.0%1
Class II + class III AAD27.7%54.8%0.0024
Pulmonary vein isolation2.5%30.9%<0.0001

Data presented as mean ± SD. AF, atrial fibrillation; AAD, antiarrhythmic drug; AVN, AV node. p values describe differences between patients with paroxysmal, persistent, and permanent AF. The bold values indicate the significance of p values.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.